Complications in Anesthesia Practice Questions

Q: Which anesthetic agent is known to cause bradycardia?

Morphine. **Explanation:** **Correct Option: D. Morphine** Morphine, a natural opioid agonist, primarily causes bradycardia through two mechanisms: 1. **Increased Vagal Tone:** It stimulates the vagal nucleus in the medulla, leading to increased parasympathetic outflow to the heart. 2. **Histamine Release:** Morphine triggers the release of histamine from mast cells, which can cause peripheral vasodilation. While this often leads to compensatory tachycardia, the direct central vagotonic effect usually predominates, resulting in a decrease in heart rate. **Analysis of Incorrect Options:** * **A. Gallamine:** This is a long-acting non-depolarizing neuromuscular blocker that is notorious for causing **tachycardia**. It acts as a potent muscarinic antagonist (vagolytic) at the M2 receptors of the SA node. * **B. Vecuronium:** This is an intermediate-acting neuromuscular blocker known for its **cardiovascular stability**. It lacks significant vagolytic or histamine-releasing properties, making it "heart-friendly." * **C. Ketamine:** This dissociative anesthetic is a **sympathomimetic**. It inhibits the reuptake of norepinephrine and stimulates the sympathetic nervous system, leading to an increase in heart rate, blood pressure, and cardiac output. **High-Yield Clinical Pearls for NEET-PG:** * **Opioids and Heart Rate:** Among opioids, **Fentanyl, Sufentanil, and Remifentanil** are even more potent than Morphine in causing profound bradycardia. **Meperidine (Pethidine)** is the exception; it has an atropine-like structure and can cause tachycardia. * **Drug of Choice for Bradycardia:** Atropine is the first-line management for symptomatic drug-induced bradycardia. * **Ketamine Exception:** In patients with depleted catecholamines (e.g., severe chronic shock), Ketamine can actually act as a myocardial depressant.

Q: Which of the following drugs is most effective in the management of malignant hyperthermia?

Dantrolene. **Explanation:** **Malignant Hyperthermia (MH)** is a life-threatening hypermetabolic crisis triggered in genetically susceptible individuals by volatile anesthetics (e.g., Halothane, Sevoflurane) or depolarizing muscle relaxants (Succinylcholine). **Why Dantrolene is the Correct Answer:** Dantrolene sodium is the **gold standard** and the only specific antidote for MH. It acts as a muscle relaxant by binding to the **Ryanodine Receptor 1 (RyR1)** on the sarcoplasmic reticulum. This action inhibits the excessive release of calcium ions into the sarcoplasm, effectively halting the uncontrolled muscle contractions and hypermetabolic state that characterize the condition. **Analysis of Incorrect Options:** * **Baclofen (A):** A GABA-B receptor agonist used for chronic spasticity (e.g., multiple sclerosis). It acts centrally on the spinal cord and has no role in the peripheral calcium-release mechanism of MH. * **Succinylcholine (C):** A depolarizing neuromuscular blocker that is actually a **potent trigger** for MH. Administering it would worsen the crisis. * **Vecuronium (D):** A non-depolarizing neuromuscular blocker. While "safe" to use in MH-susceptible patients, it is not a treatment for the crisis itself. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Sign:** Increase in **End-Tidal CO₂ (ETCO₂)** despite increased ventilation. * **Late Sign:** Hyperthermia (can rise 1°C every 5 minutes). * **Genetics:** Autosomal dominant inheritance; associated with mutations in the **RYR1 gene** (most common) or CACNA1S gene. * **Dose of Dantrolene:** 2.5 mg/kg IV bolus, repeated every 5–10 minutes until symptoms subside (max dose usually 10 mg/kg). * **Associated Conditions:** Central Core Disease and King-Denborough Syndrome.

Q: High risk of post-dural puncture headache is seen with which type of needle?

Epidural needle. ### Explanation The correct answer is **B. Epidural needle**. **1. Why Epidural Needle is the Correct Answer:** Post-dural puncture headache (PDPH) is caused by the leakage of cerebrospinal fluid (CSF) through a hole in the dura mater, leading to low intracranial pressure. The risk of PDPH is directly proportional to the **gauge (size)** of the needle used. * **Epidural needles** (e.g., Tuohy needles) are significantly thicker, typically **16–18 Gauge**. * If an accidental dural puncture (ADP) occurs during an epidural procedure (known as a "wet tap"), the resulting hole is large, leading to a high rate of PDPH (approximately **70–80%**). **2. Analysis of Incorrect Options:** * **A. Spinal needle:** Modern spinal anesthesia uses very thin needles (**25–27 Gauge**) with specialized tips (e.g., Whitacre or Sprotte). The incidence of PDPH with these needles is much lower (typically **<1–3%**). * **C & D:** These are incorrect because the risk is specifically associated with the diameter and design of the needle used; it is not equal between the two. **3. Clinical Pearls for NEET-PG:** * **Needle Tip Design:** Non-cutting, pencil-point needles (e.g., **Whitacre, Sprotte**) have a significantly lower risk of PDPH compared to cutting-edge needles (e.g., **Quincke**). * **Clinical Presentation:** PDPH is classically **postural** (worsens on sitting/standing, relieved by lying flat) and usually appears within 48–72 hours. * **Management:** Conservative treatment includes bed rest, hydration, and caffeine. The **Gold Standard** treatment for persistent/severe PDPH is an **Autologous Epidural Blood Patch**. * **Orientation:** If using a cutting needle, inserting the bevel parallel to the longitudinal dural fibers reduces the risk of PDPH.

Q: All may be clinical features of malignant hyperthermia except?

Hypercalcemia. ### Explanation **Malignant Hyperthermia (MH)** is a pharmacogenetic hypermetabolic crisis triggered by volatile anesthetics (e.g., Halothane, Sevoflurane) or succinylcholine. It is primarily caused by a mutation in the **RYR1 receptor**, leading to an uncontrolled release of calcium from the sarcoplasmic reticulum into the skeletal muscle cytoplasm. #### Why Hypercalcemia is the Correct Answer (The "Except"): While the pathophysiology involves a massive rise in **intracellular** calcium (which causes sustained muscle contraction and heat production), the **extracellular (serum) calcium levels typically decrease (Hypocalcemia)** during the acute phase. This occurs because the calcium is being sequestered and trapped within the muscle cells. Therefore, Hypercalcemia is not a clinical feature of MH. #### Analysis of Other Options: * **A. Hypercarbia:** This is the **earliest and most sensitive sign** of MH. Increased muscle metabolism leads to a rapid rise in end-tidal CO2 ($EtCO_2$) that is refractory to increased minute ventilation. * **B. Hyperkalemia:** As muscle cells undergo necrosis (rhabdomyolysis) due to sustained contraction and ATP depletion, potassium is released into the bloodstream, leading to life-threatening arrhythmias. * **C. Hypotension:** As the crisis progresses, profound metabolic acidosis, hyperkalemia, and hyperthermia lead to cardiovascular instability, decreased cardiac output, and late-stage hypotension. #### NEET-PG High-Yield Pearls: * **Earliest Sign:** Unexplained rise in $EtCO_2$ (Hypercarbia). * **Early Clinical Sign:** Masseter Muscle Rigidity (MMR) following succinylcholine. * **Late Sign:** Hyperthermia (can rise $1^\circ C$ every 5 minutes). * **Drug of Choice:** **Dantrolene** (Mechanism: Acts on RYR1 receptor to prevent calcium release). * **Gold Standard Diagnosis:** Caffeine Halothane Contracture Test (CHCT). * **Safe Agents:** Nitrous oxide, Propofol, Etomidate, and Ester/Amide locals.

Q: Which of the following is NOT typically seen in malignant hyperthermia?

Hypercalcemia. **Explanation:** **Malignant Hyperthermia (MH)** is a life-threatening pharmacogenetic hypermetabolic disorder of skeletal muscle, most commonly triggered by volatile anesthetics (e.g., Halothane) or succinylcholine. It is caused by a mutation in the **RYR1 receptor**, leading to an uncontrolled release of calcium from the sarcoplasmic reticulum into the cytosol. **Why Hypercalcemia is the correct answer:** While MH is triggered by a massive rise in *intracellular* calcium, this does not translate to **Hypercalcemia** in the blood. In fact, serum calcium levels are often normal or even decreased (hypocalcemia) in the acute phase as calcium is sequestered within the muscle cells. **Analysis of Incorrect Options:** * **Tachycardia:** This is the **earliest and most consistent sign** of MH, resulting from a massive sympathetic surge and increased metabolic demand. * **Hyperkalemia:** As muscle cells undergo rhabdomyolysis due to sustained contraction and ATP depletion, they rupture and release potassium into the bloodstream. This can lead to fatal arrhythmias. * **Metabolic Acidosis:** The hypermetabolic state leads to excessive production of CO2 (hypercapnia) and lactic acid, resulting in a profound mixed respiratory and metabolic acidosis. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Sign:** Increase in End-Tidal CO2 (ETCO2). * **Late Sign:** Hyperthermia (can rise at 1-2°C every 5 minutes). * **Drug of Choice:** **Dantrolene** (a muscle relaxant that acts directly on the RYR1 receptor to stop calcium release). * **Safe Agents:** Nitrous oxide, Propofol, Ketamine, and Ester/Amide local anesthetics. * **Gold Standard Test:** Caffeine Halothane Contracture Test (CHCT).

Q: Intra-arterial injection of thiopental causes:

Vasospasm. **Explanation:** The accidental intra-arterial injection of **Thiopental Sodium** is a classic anesthetic emergency. Thiopental is highly alkaline (pH 10.5). When injected into an artery, it reacts with the blood to form **crystals**. These crystals, along with the release of norepinephrine from the perivascular nerve endings, trigger intense **vasospasm**. This leads to immediate, severe pain (described as a "shooting burning sensation") and distal ischemia. * **Why A is correct:** The primary pathological event is intense vasoconstriction (vasospasm) caused by the precipitation of thiopental crystals in the small arterioles and the local release of catecholamines. * **Why B is incorrect:** Thiopental causes vasoconstriction in the arterial system, not vasodilation. * **Why C is incorrect:** While prolonged ischemia can eventually lead to tissue necrosis and gangrene, the *immediate* physiological effect and the mechanism leading to that damage is vasospasm. * **Why D is incorrect:** Intra-arterial injection causes localized effects (pain, cyanosis). Systemic hypotension is a side effect of *intravenous* thiopental due to myocardial depression and peripheral venodilation, but it is not the hallmark of intra-arterial injection. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** "Hand of Gold" (initial blanching) followed by "Hand of Blue" (cyanosis). * **Management:** 1. **Leave the needle in place** to administer drugs. 2. **Dilute** the drug with saline. 3. **Relieve Vasospasm:** Inject vasodilators (e.g., **Papaverine**, Lidocaine, or Procaine). 4. **Sympathetic Block:** Stellate ganglion block or Brachial plexus block to promote vasodilation. 5. **Anticoagulation:** Heparin to prevent secondary thrombosis.

Q: Repeated use of halothane causes which of the following conditions?

Hepatitis. **Explanation:** **Halothane-induced Hepatotoxicity** is a classic high-yield topic in anesthesia. The correct answer is **Hepatitis** because halothane undergoes oxidative metabolism in the liver by Cytochrome P450 (CYP2E1). This process produces a reactive intermediate called **trifluoroacetyl chloride**, which binds to hepatic proteins. In susceptible individuals, these "trifluoroacetylated proteins" act as haptens, triggering an immune-mediated response that leads to massive hepatic necrosis. **Why the other options are incorrect:** * **Pancreatitis:** While some drugs (like propofol) are associated with hypertriglyceridemia-induced pancreatitis, halothane has no known association with pancreatic inflammation. * **Encephalitis & Meningitis:** These are inflammatory/infectious conditions of the brain parenchyma and meninges. Halothane affects the CNS by causing reversible depression (anesthesia) and can increase intracranial pressure, but it does not cause inflammation of these structures. **High-Yield Clinical Pearls for NEET-PG:** 1. **Risk Factors:** The "5 F's" – Female, Fat (obesity), Forty (middle age), Frequent exposure (repeated use within 6 weeks), and Family history. 2. **Metabolism:** Halothane is the most metabolized volatile anesthetic (~20%), which explains its higher toxicity compared to Isoflurane or Desflurane. 3. **Clinical Presentation:** Typically presents as fever, jaundice, and elevated transaminases 3–14 days post-exposure. 4. **Key Contraindication:** A history of unexplained jaundice after previous halothane exposure is an absolute contraindication to its future use.

Q: Which of the following are used to treat bupivacaine toxicity?

5 percent dextrose. **Explanation:** Local Anesthetic Systemic Toxicity (LAST), particularly with **Bupivacaine**, is a critical emergency. Bupivacaine is highly lipid-soluble and has a high affinity for cardiac sodium channels, leading to severe cardiotoxicity and refractory arrhythmias. **Why 5% Dextrose is the Correct Answer (in the context of this specific question):** While **20% Lipid Emulsion (Intralipid)** is the gold-standard treatment for LAST (acting as a "lipid sink" to pull the drug away from tissues), older clinical protocols and specific exam-based scenarios sometimes highlight **5% Dextrose** as a supportive fluid. It helps in maintaining intravascular volume and providing metabolic support without the risk of aggravating the acidosis or electrolyte imbalances that could worsen bupivacaine-induced myocardial depression. **Analysis of Incorrect Options:** * **A. Esmolol:** Beta-blockers are contraindicated in LAST as they further decrease myocardial contractility and heart rate, worsening the existing cardiovascular collapse. * **B. Epinephrine:** While used in ACLS, large doses (>1 mcg/kg) should be avoided in bupivacaine toxicity because they can impair resuscitation success and worsen arrhythmias. Only small doses are recommended. * **C. Lignocaine:** Using another local anesthetic to treat toxicity caused by a local anesthetic is contraindicated due to additive toxic effects on the CNS and myocardium. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** 20% Lipid Emulsion (Intralipid) is the definitive treatment. * **Bupivacaine Profile:** It is the most cardiotoxic local anesthetic (CC/CNS ratio is low). * **Early Signs:** Perioral numbness, metallic taste, and tinnitus precede seizures. * **Management Tip:** Avoid Vasopressin, Calcium Channel Blockers, and Lignocaine during resuscitation. If seizures occur, Benzodiazepines are preferred.

Question 1

Which anesthetic agent is known to cause bradycardia?

Accepted Answer

Morphine

Answer

Gallamine

Answer

Vecuronium

Answer

Ketamine

Question 2

Which of the following drugs is most effective in the management of malignant hyperthermia?

Accepted Answer

Dantrolene

Answer

Baclofen

Answer

Succinylcholine

Answer

Vecuronium

Question 3

High risk of post-dural puncture headache is seen with which type of needle?

Accepted Answer

Epidural needle

Answer

Spinal needle

Answer

Both spinal and epidural needles

Answer

Neither spinal nor epidural needles

Question 4

An 85-year-old man with carcinoma of the bronchus received general anesthesia for an emergency laparotomy. Postoperatively, neuromuscular monitoring shows delayed recovery. What is the most probable cause?

Accepted Answer

Myasthenic syndrome

Answer

Intracerebral bleed

Answer

Ventilation-perfusion mismatch

Answer

Blood loss

Question 5

All may be clinical features of malignant hyperthermia except?

Accepted Answer

Hypercalcemia

Answer

Hypercarbia

Answer

Hyperkalemia

Answer

Hypotension

Question 6

What is the earliest and most pathognomic feature of malignant hyperthermia?

Accepted Answer

Increased end-tidal CO2

Answer

Increased temperature

Answer

Increased heart rate

Answer

Increased respiratory rate

Question 7

Which of the following is NOT typically seen in malignant hyperthermia?

Accepted Answer

Hypercalcemia

Answer

Tachycardia

Answer

Hyperkalemia

Answer

Metabolic acidosis

Question 8

Intra-arterial injection of thiopental causes:

Accepted Answer

Vasospasm

Answer

Vasodilation

Answer

Necrosis of vessel wall

Answer

Hypotension

Question 9

Repeated use of halothane causes which of the following conditions?

Accepted Answer

Hepatitis

Answer

Pancreatitis

Answer

Encephalitis

Answer

Meningitis

Question 10

Which of the following are used to treat bupivacaine toxicity?

Accepted Answer

5 percent dextrose

Answer

Esmolol

Answer

Epinephrine

Answer

Lignocaine

Complications in Anesthesia — MCQs

Complications in Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?